CN102942545B - Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester - Google Patents
Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester Download PDFInfo
- Publication number
- CN102942545B CN102942545B CN201210524106.2A CN201210524106A CN102942545B CN 102942545 B CN102942545 B CN 102942545B CN 201210524106 A CN201210524106 A CN 201210524106A CN 102942545 B CN102942545 B CN 102942545B
- Authority
- CN
- China
- Prior art keywords
- nepetalactone
- bromobenzoic acid
- schizonepetolactone
- acid ester
- domestic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XRXMNWGCKISMOH-UHFFFAOYSA-N 2-bromobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Br XRXMNWGCKISMOH-UHFFFAOYSA-N 0.000 claims abstract description 46
- 239000003814 drug Substances 0.000 claims abstract description 7
- 230000003602 anti-herpes Effects 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 23
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 18
- 239000000741 silica gel Substances 0.000 claims description 17
- 229910002027 silica gel Inorganic materials 0.000 claims description 17
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 14
- 238000004440 column chromatography Methods 0.000 claims description 14
- -1 o-bromobenzoic acid ester Chemical class 0.000 claims description 14
- 239000003208 petroleum Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims 2
- 238000005352 clarification Methods 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- ZDKZHVNKFOXMND-UHFFFAOYSA-N cis-Nepetalactone Natural products O=C1OC=C(C)C2C1C(C)CC2 ZDKZHVNKFOXMND-UHFFFAOYSA-N 0.000 abstract description 56
- ZDKZHVNKFOXMND-NBEYISGCSA-N cis-trans-nepetalactone Chemical compound O=C1OC=C(C)[C@@H]2[C@H]1[C@@H](C)CC2 ZDKZHVNKFOXMND-NBEYISGCSA-N 0.000 abstract description 55
- 238000002844 melting Methods 0.000 abstract description 2
- 230000008018 melting Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 22
- 239000003480 eluent Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 241001529733 Nepeta Species 0.000 description 7
- 241000207923 Lamiaceae Species 0.000 description 6
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000001256 steam distillation Methods 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000003501 vero cell Anatomy 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000143437 Aciculosporium take Species 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940124397 anti-herpes virus drug Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 201000010666 keratoconjunctivitis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种荆芥内酯邻溴苯甲酸酯及其制备工艺和用途,荆芥内酯邻溴苯甲酸酯,其特征是分子式为C17H17BrO4,熔点为184-186℃,其比旋度为本发明还公开了它的提取方法,以及在制备抗疱疹病毒药物中的应用。
The invention discloses a nepetalactone o-bromobenzoate and its preparation process and application. The nepetalactone o-bromobenzoate is characterized in that the molecular formula is C 17 H 17 BrO 4 and the melting point is 184- 186℃, its specific rotation is The invention also discloses its extraction method and its application in the preparation of anti-herpes virus medicine.
Description
技术领域 technical field
本发明涉及一种荆芥内酯邻溴苯甲酸酯及其制备工艺和用途,属于药物制剂技术领域。The invention relates to a nepetalactone o-bromobenzoate, a preparation process and application thereof, and belongs to the technical field of pharmaceutical preparations.
背景技术 Background technique
荆芥内酯(C10H14O3)为由中药材荆芥中提取而得的一种单萜内酯,为无色粒晶(乙酸乙酯),mp:188~189℃。TLC显红色(10%硫酸乙醇),分子式为C10H14O3,其结构式为Nepetalactone (C 10 H 14 O 3 ) is a monoterpene lactone extracted from the Chinese herbal medicine Nepeta chinensis. It is a colorless crystal (ethyl acetate), mp: 188-189°C. TLC is red (10% ethanol sulfate), molecular formula is C 10 H 14 O 3 , and its structural formula is
中国专利CN01108186.4披露了荆芥内酯的结构图谱及其用途,其可以用来制备抗感冒药物、消炎药物、抗菌药物、镇痛剂等,中国专利CN201010217622.1披露了荆芥内酯的一种改进制备工艺,使得荆芥内酯的制备操作简化、得率提高、生产成本降低。疱疹病毒的感会导致人类多种疾病,如唇疱疹、生殖器疱疹、慢性粘膜溃疡、角膜结膜炎、脑膜炎等,这些临床症状从轻微到严重不等,在某些情况下甚至会威胁生命。荆芥内酯在体外对疱疹病毒作用力较弱,为了获得更强抗疱疹病毒作用的药物,拟通过结构改造,以获得具有更强体外抗疱疹病毒活性的荆芥内酯衍生物。迄今为止,尚未有报道由荆芥内酯经邻溴苯甲酸酯化后得到荆芥内酯邻溴苯甲酸酯。Chinese patent CN01108186.4 discloses the structural map of nepetalactone and its use, which can be used to prepare anti-cold drugs, anti-inflammatory drugs, antibacterial drugs, analgesics, etc. Chinese patent CN201010217622.1 discloses the structure of nepetalactone An improved preparation process simplifies the preparation operation of nepetalactone, improves the yield and reduces the production cost. Infection with herpes virus can cause a variety of human diseases, such as cold sores, genital herpes, chronic mucosal ulcers, keratoconjunctivitis, meningitis, etc. These clinical symptoms range from mild to severe, and in some cases even life-threatening. Nepetalactone has a weak effect on herpes virus in vitro. In order to obtain a drug with stronger anti-herpes virus effect, it is planned to obtain a nepetalactone derivative with stronger in vitro anti-herpes virus activity through structural modification. So far, there is no report of obtaining nepetalactone o-bromobenzoate from nepetalactone through o-bromobenzoate esterification.
发明内容 Contents of the invention
本发明的目的在于提供一种由荆芥内酯经邻溴苯甲酸酯化后得到荆芥内酯邻溴苯甲酸酯以及它的制备方法和作为药物的用途。The object of the present invention is to provide a kind of nepetalactone o-bromobenzoic acid ester obtained by esterifying nepetalactone with o-bromobenzoic acid ester, its preparation method and its use as medicine.
本发明的技术方案如下述Technical scheme of the present invention is as follows
荆芥内酯邻溴苯甲酸酯,其特征是分子式为C17H17BrO4,熔点为184-186℃,其比旋度为它的结构式如下所示,本发明人暂命名为荆芥内酯邻溴苯甲酸酯:Nepetalactone o-bromobenzoate is characterized by a molecular formula of C 17 H 17 BrO 4 , a melting point of 184-186°C, and a specific rotation of Its structural formula is as follows, the inventor tentatively named nepetalactone o-bromobenzoate:
本发明的荆芥内酯邻溴苯甲酸酯制备方法包括如下步骤:The preparation method of nepetalactone o-bromobenzoate of the present invention comprises the steps:
A.取荆芥内酯,邻溴苯甲酸和4-二甲氨基吡啶(DMAP)适量,此三种物质物质的量比例为0.5~1.5∶1.5~2.5∶0.5~1.5,置于反应容器中,加入二氯甲烷,搅拌使其完全溶解,加入N,N’-二环己基碳二亚胺(DCC)或1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDCI),此两种物质物质的量是荆芥内酯的1.5~2.5倍,于室温反应,TLC检验反应终点,得反应液;A. Take an appropriate amount of nepetalactone, o-bromobenzoic acid and 4-dimethylaminopyridine (DMAP), the ratio of these three substances is 0.5~1.5: 1.5~2.5: 0.5~1.5, and place them in the reaction vessel , add dichloromethane, stir to dissolve completely, add N, N'-dicyclohexylcarbodiimide (DCC) or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide salt salt (EDCI), the amount of these two substances is 1.5 to 2.5 times that of nepetalactone, react at room temperature, TLC checks the reaction end point, and obtains the reaction solution;
B.将A步骤所得反应液,滴加甲醇使溶液澄清,加入硅胶,减压蒸馏溶剂至干,得硅胶混合样。B. Add methanol dropwise to the reaction solution obtained in step A to clarify the solution, add silica gel, and distill the solvent to dryness under reduced pressure to obtain a silica gel mixed sample.
C.将B步骤所得硅胶混合样装柱进行柱层析,用体积配比为4~7∶1的石油醚-乙酸乙酯进行洗脱,收集含有荆芥内酯邻溴苯甲酸酯的流份,合并后减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体。C. Pack the silica gel mixed sample obtained in step B into a column for column chromatography, elute with sherwood oil-ethyl acetate with a volume ratio of 4 to 7: 1, and collect the mixture containing nepetalactone o-bromobenzoate The fractions were combined and the eluent was recovered under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate.
上述步骤A中荆芥内酯邻溴苯甲酸酯的制备方法,荆芥内酯,邻溴苯甲酸和4-二甲氨基吡啶三种物质物质的量比例为1∶2∶1;加入的N,N’-二环己基碳二亚胺或1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐,此两种物质物质的量是荆芥内酯的2倍;步骤C中石油醚-乙酸乙酯的体积配比为5∶1。The preparation method of nepetalactone o-bromobenzoate in the above step A, the amount ratio of nepetalactone, o-bromobenzoic acid and 4-dimethylaminopyridine three substances is 1:2:1; N, N'-dicyclohexylcarbodiimide or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, the amount of these two substances is that of nepetalactone 2 times; the volume ratio of petroleum ether-ethyl acetate in step C is 5:1.
荆芥内酯邻溴苯甲酸酯的体外抗疱疹病毒药效学试验表明,它具有较好的抗HSV-1活性,因此可用于制备抗疱疹病毒药物。The in vitro anti-herpes virus pharmacodynamics test of nepetalactone o-bromobenzoate shows that it has good anti-HSV-1 activity, so it can be used to prepare anti-herpes virus drugs.
本发明的荆芥内酯邻溴苯甲酸酯是一种新的薄荷烷型单萜类化合物,它结构简单,制备方法简便价廉,且具有较强的生理活性。The nepetalactone o-bromobenzoate of the present invention is a novel menthane-type monoterpenoid compound, which has a simple structure, a simple and cheap preparation method, and strong physiological activity.
附图说明 Description of drawings
图1化合物荆芥内酯邻溴苯甲酸酯的紫外光谱图,λmax(CH3OH):277.6nm,提示化合物具有共轭吸收特征Figure 1 The UV spectrum of the compound nepetalactone o-bromobenzoate, λ max (CH 3 OH): 277.6nm, suggesting that the compound has conjugated absorption characteristics
图2化合物荆芥内酯邻溴苯甲酸酯的HPLC纯度图谱,归一化法进行计算得荆芥内酯邻溴苯甲酸酯纯度为97.3%。The HPLC purity spectrum of the compound nepetalactone o-bromobenzoate in Fig. 2, the purity of nepetalactone o-bromobenzoate calculated by normalization method is 97.3%.
具体实施方式 Detailed ways
以下通过实施例形式,对本发明涉及的荆芥内酯邻溴苯甲酸酯及其制备方法作进一步的详细说明,但不应将此理解为本发明上述主题的范围仅限于以下的实例,凡基于本发明上述内容所实现的技术均属于本发明的范围。Below by way of example, the nepetalactone o-bromobenzoic acid ester that the present invention relates to and preparation method thereof are described in further detail, but this should not be interpreted as the scope of the above-mentioned theme of the present invention being limited to following examples, where The technologies realized based on the above contents of the present invention all belong to the scope of the present invention.
实施例1:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)18.2mg(0.10mmol),邻溴苯甲酸50.2mg(0.25mmol,国产AR级),DMAP 12.3mg(0.10mmol,国产AR级),将其置于50mL圆底烧瓶中,加入4mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入DCC 51.6mg(0.25mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约500mg,减压蒸馏溶剂至干。称取5g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=5∶1)洗脱,洗脱40mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约30mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色粉末,纯度为97%以上,收率81%。Example 1: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 18.2mg (0.10mmol), o-bromobenzoic acid 50.2mg (0.25mmol, domestic AR grade), DMAP 12.3mg (0.10mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 4mL of dichloromethane (domestic AR grade), stir to dissolve completely, add DCC 51.6mg (0.25mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, methanol (domestic AR grade) was added dropwise to clarify the solution, and about 500 mg of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) was added in three times, and the solvent was distilled under reduced pressure to dryness. Weigh 5g of silica gel (produced by Qingdao Haiyang Chemical Factory, for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=5:1) When the elution is about 40mL, the target compound nepetalactone o-bromobenzoate can be found by TLC tracking. At this time, the eluate is collected and collected every 5mL. When about 30mL, the TLC tracking shows that the target compound has been basically completely eluted. The eluents are combined, and the eluents are recovered under reduced pressure to obtain a yellow powder of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 81%.
实施例2:Example 2:
实施例1制备得到的荆芥内酯邻溴苯甲酸酯结构解析:Structural analysis of the nepetalactone o-bromobenzoate prepared in Example 1:
HR-ESI-MS:m/z 366.0415[M+H]+(计算值C17H17BrO4为:365.2185);[α]20.3 D,+82.5°(c 1.0,CH3OH)。HR-ESI-MS: m/z 366.0415 [M+H] + (calcd for C 17 H 17 BrO 4 : 365.2185); [α] 20.3 D , +82.5° (c 1.0, CH 3 OH).
IR(KBr压片,cm-1):3028(νΦ-H);2931,2848(饱和环烃νCH);1754(内酯羰基νC=O);1697(羰基νC=O);1627,1572,1503,1447(共轭苯环νC=C);864,792,689(苯环间位取代γΦ-H)。IR (KBr tablet, cm -1 ): 3028 (ν Φ-H ); 2931, 2848 (saturated cyclic hydrocarbon ν CH ); 1754 (lactone carbonyl ν C=O ); 1697 (carbonyl ν C=O ); 1627, 1572, 1503, 1447 (conjugated benzene ring ν C=C ); 864, 792, 689 (benzene ring meta-substituted γ Φ-H ).
UV(CH3OH)λmax:277.6nm,提示化合物具有共轭吸收特征。见附图1UV(CH 3 OH)λ max : 277.6nm, suggesting that the compound has conjugated absorption characteristics. See Attachment 1
H1-NMR(300MHz,CDCl3,ppm):δ1.01(d,3H,J=6.6Hz,6’-CH3),1.11(dd,1H,J=4.2,13.2Hz,5a-H),1.26(m,1H,4a-H),1.90(s,3H,3’-H),1.99-2.10(m,2H,5b-H,6-H),2.37(m,1H,4b-H),2.79-2.86(m,2H,7-H),7.32-7.39(m,2H,Ar-H),7.65(dd,1H,J=0.9,4.5Hz,Ar-H),7.75(dd,1H,J=1.2,4.5Hz,Ar-H)。H 1 -NMR (300MHz, CDCl 3 , ppm): δ1.01 (d, 3H, J=6.6Hz, 6'-CH 3 ), 1.11 (dd, 1H, J=4.2, 13.2Hz, 5a-H) , 1.26(m, 1H, 4a-H), 1.90(s, 3H, 3'-H), 1.99-2.10(m, 2H, 5b-H, 6-H), 2.37(m, 1H, 4b-H ), 2.79-2.86(m, 2H, 7-H), 7.32-7.39(m, 2H, Ar-H), 7.65(dd, 1H, J=0.9, 4.5Hz, Ar-H), 7.75(dd, 1H, J = 1.2, 4.5 Hz, Ar-H).
13C NMR(75MHz,CDCl3,ppm):δ171.3(C-8),163.4(C-7’),157.9(C-3),134.3(C-1’),132.8,131.5(C-2’,C-6’),127.3,123.1(C-3’,C-5’),122.2(C-4’),121.3(C-7),104.5(C-4),45.0(C-5),34.5(C-1),28.6(C6),24.4(C-2),20.9(C-10),8.3(C-9)。 13 C NMR (75MHz, CDCl 3 , ppm): δ171.3 (C-8), 163.4 (C-7'), 157.9 (C-3), 134.3 (C-1'), 132.8, 131.5 (C- 2', C-6'), 127.3, 123.1 (C-3', C-5'), 122.2 (C-4'), 121.3 (C-7), 104.5 (C-4), 45.0 (C- 5), 34.5(C-1), 28.6(C6), 24.4(C-2), 20.9(C-10), 8.3(C-9).
荆芥内酯邻溴苯甲酸酯纯度:利用HPLC法进行检测,荆芥内酯邻溴苯甲酸酯峰面积为16945496,杂质总峰面积为469154,采用归一化法进行计算得荆芥内酯邻溴苯甲酸酯纯度为97.3%。见附图2Purity of nepetalactone o-bromobenzoate: detected by HPLC method, the peak area of nepetalactone o-bromobenzoate is 16945496, the total peak area of impurities is 469154, and the normalization method is used to calculate the nepetalactone o-bromobenzoate The purity of lactone o-bromobenzoate was 97.3%. See Attachment 2
实施例3:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)18.2mg(0.10mmol),邻溴苯甲酸50.2mg(0.25mmol,国产AR级),DMAP 12.3mg(0.10mmol,国产AR级),将其置于50mL圆底烧瓶中,加入4mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入EDCI 47.9mg(0.25mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约500mg,减压蒸馏溶剂至干。称取5g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=5∶1)洗脱,洗脱40mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约30mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体,纯度为97%以上,收率83%。Example 3: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 18.2mg (0.10mmol), o-bromobenzoic acid 50.2mg (0.25mmol, domestic AR grade), DMAP 12.3mg (0.10mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 4mL of dichloromethane (domestic AR grade), stir to dissolve completely, add EDCI 47.9mg (0.25mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, methanol (domestic AR grade) was added dropwise to clarify the solution, and about 500 mg of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) was added in three times, and the solvent was distilled under reduced pressure to dryness. Weigh 5g of silica gel (produced by Qingdao Haiyang Chemical Factory, for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=5:1) When the elution is about 40mL, the target compound nepetalactone o-bromobenzoate can be found by TLC tracking. At this time, the eluate is collected and collected every 5mL. When about 30mL, the TLC tracking shows that the target compound has been basically completely eluted. The eluents were combined, and the eluents were recovered under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 83%.
实施例4:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)24.3mg(0.15mmol),邻溴苯甲酸64.3mg(0.32mmol,国产AR级),DMAP 18.5mg(0.15mmol,国产AR级),将其置于50mL圆底烧瓶中,加入4mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入DCC 66.1mg(0.32mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约550mg,减压蒸馏溶剂至干。称取5g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=6∶1)洗脱,洗脱45mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约35mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体,纯度为97%以上,收率87%。Example 4: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 24.3mg (0.15mmol), o-bromobenzoic acid 64.3mg (0.32mmol, domestic AR grade), DMAP 18.5mg (0.15mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 4mL of dichloromethane (domestic AR grade), stir to dissolve completely, add DCC 66.1mg (0.32mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, add methanol (domestic AR grade) dropwise to clarify the solution, add about 550 mg of silica gel (produced by Qingdao Ocean Chemical Factory, for column chromatography) three times the amount, and distill the solvent to dryness under reduced pressure. Weigh 5g of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=6:1) When the elution is about 45mL, the target compound nepetalactone o-bromobenzoate can be found by TLC tracking. At this time, the eluate is collected and collected every 5mL. When it is about 35mL, the TLC tracking shows that the target compound has been basically completely washed out. decompression, combined eluents, and recovered the eluents under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 87%.
实施例5:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)24.3mg(0.15mmol),邻溴苯甲酸64.3mg(0.32mmol,国产AR级),DMAP 18.5mg(0.15mmol,国产AR级),将其置于50mL圆底烧瓶中,加入4mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入EDCI 61.3mg(0.32mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约550mg,减压蒸馏溶剂至干。称取5g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=6∶1)洗脱,洗脱45mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约35mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体,纯度为97%以上,收率83%。Example 5: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 24.3mg (0.15mmol), o-bromobenzoic acid 64.3mg (0.32mmol, domestic AR grade), DMAP 18.5mg (0.15mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 4mL of dichloromethane (domestic AR grade), stir to dissolve completely, add EDCI 61.3mg (0.32mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, add methanol (domestic AR grade) dropwise to clarify the solution, add about 550 mg of silica gel (produced by Qingdao Ocean Chemical Factory, for column chromatography) three times the amount, and distill the solvent to dryness under reduced pressure. Weigh 5g of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=6:1) When the elution is about 45mL, the target compound nepetalactone o-bromobenzoate can be found by TLC tracking. At this time, the eluate is collected and collected every 5mL. When it is about 35mL, the TLC tracking shows that the target compound has been basically completely washed out. The eluents were combined, and the eluents were recovered under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 83%.
实施例6:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)36.5mg(0.20mmol),邻溴苯甲酸76.3mg(0.38mmol,国产AR级),DMAP 24.5mg(0.20mmol,国产AR级),将其置于50mL圆底烧瓶中,加入5mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入DCC 78.5mg(0.38mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约600mg,减压蒸馏溶剂至干。称取6g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=7∶1)洗脱,洗脱50mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约40mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体,纯度为97%以上,收率85%。Example 6: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 36.5mg (0.20mmol), o-bromobenzoic acid 76.3mg (0.38mmol, domestic AR grade), DMAP 24.5mg (0.20mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 5mL of dichloromethane (domestic AR grade), stir to dissolve completely, add DCC 78.5mg (0.38mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, methanol (domestic AR grade) was added dropwise to clarify the solution, and about 600 mg of silica gel (produced by Qingdao Ocean Chemical Factory, for column chromatography) was added in three times the amount, and the solvent was distilled to dryness under reduced pressure. Weigh 6g of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=7:1) When about 50mL was eluted, the target compound nepetalactone o-bromobenzoate could be found by TLC tracking. At this time, the eluate was collected and collected once every 5mL. When about 40mL, TLC tracking found that the target compound was basically completely eluted. decompression, combined the eluents, and recovered the eluents under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 85%.
实施例7:称取荆芥内酯(照中国专利CN201010217622.1披露的方法,采用唇形科植物荆芥Schizonepeta tenuifolia Briq.花穗以水蒸气蒸馏法提取所得的市售荆芥挥发油经氧化制备而得,纯度98%以上)36.5mg(0.20mmol),邻溴苯甲酸76.3mg(0.38mmol,国产AR级),DMAP 24.5mg(0.20mmol,国产AR级),将其置于50mL圆底烧瓶中,加入5mL二氯甲烷(国产AR级),搅拌使其完全溶解,加入EDCI 72.8mg(0.38mmol,国产AR级),于室温(20-25℃)反应,TLC检验反应终点。反应结束后,滴加甲醇(国产AR级)使溶液澄清,加入三倍量硅胶(青岛海洋化工厂出品,柱层析用)约600mg,减压蒸馏溶剂至干。称取6g硅胶(青岛海洋化工厂出品,柱层析用)装柱,洗脱剂(石油醚(60-90℃,国产AR级)∶乙酸乙酯(国产AR级)=7∶1)洗脱,洗脱50mL左右时,TLC跟踪可发现目标化合物荆芥内酯邻溴苯甲酸酯,此时收集洗脱液,每5mL收集一次,约40mL左右时TLC跟踪发现目标化合物已基本完全洗脱,合并洗脱液,减压回收洗脱液,可得荆芥内酯邻溴苯甲酸酯黄色固体,纯度为97%以上,收率86%。Example 7: Weighing nepetalactone (according to the method disclosed in Chinese patent CN201010217622.1, the commercially available nepeta volatile oil obtained by extracting the flower spikes of the Lamiaceae plant Schizonepeta tenuifolia Briq. by steam distillation was prepared by oxidation And get, purity more than 98%) 36.5mg (0.20mmol), o-bromobenzoic acid 76.3mg (0.38mmol, domestic AR grade), DMAP 24.5mg (0.20mmol, domestic AR grade), it is placed in 50mL round bottom flask Add 5mL of dichloromethane (domestic AR grade), stir to dissolve completely, add EDCI 72.8mg (0.38mmol, domestic AR grade), react at room temperature (20-25°C), and check the end point of the reaction by TLC. After the reaction, methanol (domestic AR grade) was added dropwise to clarify the solution, and about 600 mg of silica gel (produced by Qingdao Ocean Chemical Factory, for column chromatography) was added in three times the amount, and the solvent was distilled to dryness under reduced pressure. Weigh 6g of silica gel (produced by Qingdao Ocean Chemical Factory, used for column chromatography) and pack it into a column, wash with eluent (petroleum ether (60-90°C, domestic AR grade): ethyl acetate (domestic AR grade)=7:1) When about 50mL was eluted, the target compound nepetalactone o-bromobenzoate could be found by TLC tracking. At this time, the eluate was collected and collected once every 5mL. When about 40mL, TLC tracking found that the target compound was basically completely eluted. decompression, combined the eluents, and recovered the eluents under reduced pressure to obtain a yellow solid of nepetalactone o-bromobenzoate with a purity of over 97% and a yield of 86%.
实施例8荆芥内酯邻溴苯甲酸酯的抗HSV-1病毒作用The anti-HSV-1 virus effect of embodiment 8 nepetalactone o-bromobenzoate
1样品细胞毒性实验1 sample cytotoxicity test
1.1样品浓度的配制1.1 Preparation of sample concentration
按上述实施例1方法制备样品,先用二甲亚砜配制成20mg/mL。然后用Vero细胞培养液分别稀释为200μg/mL、100μg/mL、50μg/mL、25μg/mL、12.5μg/mL、6.25μg/mL、3.125μg/mL、1.562μg/mL。The sample was prepared according to the method of the above-mentioned Example 1, first formulated with dimethyl sulfoxide to 20 mg/mL. Then diluted with Vero cell culture medium to 200μg/mL, 100μg/mL, 50μg/mL, 25μg/mL, 12.5μg/mL, 6.25μg/mL, 3.125μg/mL, 1.562μg/mL.
1.2毒性测试1.2 Toxicity test
Vero细胞在96孔培养板单层培养37℃,5%CO2培养24小时,吸弃上清液,分别加入上述已配制的不同浓度药液,每个浓度4孔。经37℃,5%CO2培养箱培养72小时观察细胞形态,计算药物致细胞半数毒性TC50。Vero cells were cultured in a 96-well culture plate in a single layer at 37°C and 5% CO 2 for 24 hours, the supernatant was discarded, and the above-mentioned prepared medicinal solutions of different concentrations were added to 4 wells for each concentration. After culturing in a 37°C, 5% CO 2 incubator for 72 hours, the cell morphology was observed, and the drug-induced cytotoxicity TC 50 was calculated.
2细胞病变抑制试验2 cytopathic inhibition test
Vero细胞在96孔培养板单层培养37℃,5%CO2培养24小时,吸弃上清液,细胞经稀释液洗涤,每孔加入洗涤液100μL,吸弃洗涤液,加入10TCID50病毒液,37℃,5%CO2吸附2小时,吸去病毒,加入不同浓度的药液,每个浓度4孔。经37℃,5%CO2培养72小时,观察CPE(病变),设细胞对照组,病毒对照组,阳性对照组(阿昔洛韦)及实验药物组,同时观察CPE,抑制病变超过50%的,计算IC50(半数有效抑制浓度)及治疗指数TI值。Vero cells were cultured in a 96-well culture plate in a single layer at 37°C and 5% CO 2 for 24 hours, discarded the supernatant, washed the cells with the dilution solution, added 100 μL of the washing solution to each well, discarded the washing solution, and added 10TCID 50 virus solution , 37°C, 5% CO 2 adsorption for 2 hours, the virus was sucked off, and different concentrations of drug solutions were added, with 4 wells for each concentration. After culturing for 72 hours at 37°C and 5% CO2 , observe CPE (lesions), set up cell control group, virus control group, positive control group (acyclovir) and experimental drug group, observe CPE at the same time, and inhibit lesions by more than 50% , calculate IC 50 (half effective inhibitory concentration) and therapeutic index TI value.
3结果3 results
化合物荆芥内酯邻溴苯甲酸酯表现出较好的抗HSV-1活性,IC50为6.25μg/mL,TC50分别为29.3μg/mL,TI分别为4.69。同样条件下,荆芥内酯未表现出较好的抗HSV-1活性,因此,荆芥内酯邻溴苯甲酸酯在体外显著优于荆芥内酯的抗HSV-1活性。见表1。The compound nepetalactone o-bromobenzoate showed good anti-HSV-1 activity, with IC 50 of 6.25 μg/mL, TC 50 of 29.3 μg/mL, and TI of 4.69. Under the same conditions, nepetalactone did not show better anti-HSV-1 activity, therefore, nepetalactone o-bromobenzoate was significantly better than nepetalactone's anti-HSV-1 activity in vitro. See Table 1.
表1荆芥内酯邻溴苯甲酸酯体外抗HSV-1活性Table 1 In vitro anti-HSV-1 activity of nepetalactone o-bromobenzoate
注:“-”表示样品在TC50浓度下时未见对病毒的抑制或不予检测。Note: "-" indicates that the sample has no inhibition on the virus or is not detected at the concentration of TC50 .
TI=TC50/IC50。TI=TC 50 /IC 50 .
对病毒的抑制或不予检测。Inhibition of the virus or not detected.
TI=TC50/IC50。TI=TC 50 /IC 50 .
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210524106.2A CN102942545B (en) | 2012-12-07 | 2012-12-07 | Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210524106.2A CN102942545B (en) | 2012-12-07 | 2012-12-07 | Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102942545A CN102942545A (en) | 2013-02-27 |
CN102942545B true CN102942545B (en) | 2014-07-23 |
Family
ID=47725561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210524106.2A Expired - Fee Related CN102942545B (en) | 2012-12-07 | 2012-12-07 | Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102942545B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1174973C (en) * | 2001-04-09 | 2004-11-10 | 南京中医药大学 | Nepetalactone and its extraction process and application |
DE60314240T2 (en) * | 2002-04-03 | 2008-01-31 | E.I. Du Pont De Nemours And Co., Wilmington | PREPARATION OF DIHYDRONEPETALACTONE BY HYDROGENATION OF NEPETALACTONE |
US20060201391A1 (en) * | 2005-03-09 | 2006-09-14 | Scialdone Mark A | Compositions having sustained-release insect repellency |
CN101885715B (en) * | 2010-07-06 | 2012-05-23 | 南京中医药大学 | Preparation method for nepetalactone |
-
2012
- 2012-12-07 CN CN201210524106.2A patent/CN102942545B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102942545A (en) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101003528B (en) | En-kaurene diterpenoids and derivatives thereof, preparation methods and uses thereof | |
CN106083879A (en) | Norcantharidin mono-acid monoester derivates and antitumor application thereof | |
CN113336765B (en) | Curcumol ester compound, preparation method and application thereof in medicine for treating colorectal cancer | |
CN103694247A (en) | Compound Chaetomugilide A and preparation method and application thereof | |
CN112110897B (en) | Preparation method of deuterated crizotinib and derivative thereof | |
Kakuda et al. | Studies on the constituents of Gentiana species. II. A new triterpenoid, and (S)-(+)-and (R)-(−)-gentiolactones from Gentiana lutea | |
CN102964321B (en) | A kind of nepetalactone fluorobenzoate and its preparation process and application | |
CN102942545B (en) | Nepetalactone-o-bromobenzoic acid ester as well as preparation process and use of nepetalactone-o-bromobenzoic acid ester | |
CN102942544B (en) | Nepetalactone trifluoromethyl benzoate as well as preparation process and use of nepetalactone trifluoromethyl benzoate | |
CN108926553A (en) | A kind of flavone compound is preparing the application in topoisomerase I inhibitor | |
CN105968064A (en) | Bis(m-methylphenyl) tetrazine dicarboxamide compound as well as preparation and application thereof | |
CN101792478A (en) | Light affinity labelling small molecular probe based on maslinic acid and preparation method thereof | |
CN105949139B (en) | A kind of sec-butyl diphenyl tetrazine benzamide compound and preparation and application | |
EP3255031B1 (en) | Compound, and separation method, synthesis method and use thereof | |
CN103012338B (en) | Nepeta lactone parabromobenzoate and preparation process and application thereof | |
CN111848640B (en) | A kind of ground bile lactone compound, preparation method and application thereof | |
CN106967067A (en) | A kind of method for preparing 7 hydroxyl mitragynines | |
CN108329300B (en) | Nitrobenzo [ d ] aza-quinazoline compound and preparation method and application thereof | |
CN102558189B (en) | Refining method of methyhaaltrexone bromide | |
CN109180632B (en) | A method for preparing compound separated from radix Tripterygii Wilfordii | |
TWI518094B (en) | One kind of derivatives of sterols, their preparation and use | |
CN115073406A (en) | Eucalyptus alkane type sesquiterpene lactone TBA derivative and application thereof | |
CN105949214B (en) | Norcantharidin mono-acid sodium salt derivative and its antitumor application thereof | |
CN101434579A (en) | Fuziline esterification derivative, synthetic method and use | |
CN105503984A (en) | Hedgehog signal channel inhibitor and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 |